Little cash on hand combined with loan workouts have a way of driving out investors. It doesn't exactly inspire confidence in management's financial acumen.
Low spot and term prices aren't helping.
As far as ablation, how does WUC expect to prove out the technology without addressing the licensing issue? This needs to be resolved before larger-scale pilot tests can be conducted.
BLR Price at posting:
0.2¢ Sentiment: None Disclosure: Not Held
